Visceral Pain Treatment Market
According to Intent Market Research, the Visceral Pain Treatment Market is expected to grow from USD 4.8 billion in 2024-e at a CAGR of 23.4% to touch USD 17.0 billion by 2030. The Visceral Pain Treatment Market is dominated by key players such as Pfizer Inc., Johnson & Johnson, Novartis AG, Eli Lilly and Co., Abbott Laboratories, Sanofi S.A., GlaxoSmithKline plc, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Endo International plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim and Bristol-Myers Squibb Company.